MARTINI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 775
NA - Nord America 391
AS - Asia 169
SA - Sud America 9
AF - Africa 6
OC - Oceania 2
Totale 1.352
Nazione #
IT - Italia 504
US - Stati Uniti d'America 389
SE - Svezia 142
JP - Giappone 55
RU - Federazione Russa 40
CN - Cina 38
SG - Singapore 29
IN - India 23
TR - Turchia 17
FI - Finlandia 13
FR - Francia 11
ES - Italia 10
BR - Brasile 9
DE - Germania 9
GB - Regno Unito 7
IE - Irlanda 7
NL - Olanda 5
PL - Polonia 5
CZ - Repubblica Ceca 4
GR - Grecia 4
NO - Norvegia 4
BG - Bulgaria 3
DZ - Algeria 3
LT - Lituania 3
AT - Austria 2
HK - Hong Kong 2
IR - Iran 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
VN - Vietnam 2
AU - Australia 1
BJ - Benin 1
CA - Canada 1
MX - Messico 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
Totale 1.352
Città #
Ashburn 116
Milan 84
New York 64
Rome 41
Lawrence 28
Princeton 28
Boardman 27
Shanghai 27
Singapore 21
Pune 20
Turin 15
Florence 14
Helsinki 13
Moscow 13
Azzano San Paolo 11
Bari 9
Bologna 9
Palermo 8
Bursa 7
Dublin 7
Genoa 6
Hayamiya 6
Naples 6
Padova 6
Tokyo 6
Falconara Marittima 5
Lamezia Terme 5
Paris 5
Amsterdam 4
Ankara 4
Arcore 4
Modena 4
Montepulciano 4
Seattle 4
Washington 4
Alcamo 3
Andria 3
Athens 3
Bergamo 3
Bilbao 3
Bolzano 3
Catania 3
Cefalù 3
Chicago 3
Gohongi 3
Istanbul 3
Parma 3
Pavia 3
Shibuya 3
The Bronx 3
Trieste 3
Verona 3
Agrigento 2
Ancona 2
Barcelona 2
Borås 2
Camponogara 2
Cancello e Arnone 2
Castel Gandolfo 2
Chiampo 2
Chiyoda-ku 2
Ciserano 2
Cologne 2
Cordenons 2
Ferrara 2
Frankfurt am Main 2
Hanawada 2
Hanoi 2
Hanover 2
Holyhead 2
Hong Kong 2
Hyderabad 2
Imola 2
Jales 2
Kaunas 2
Lecce 2
London 2
Los Angeles 2
Messina 2
Miami 2
Moncalieri 2
Monza 2
Mushin 2
Niigata 2
Nogara 2
Oberschaeffolsheim 2
Oslo 2
Palhoca 2
Pisa 2
Porto Alegre 2
Prato 2
Quartu Sant'Elena 2
Redwood City 2
Rimini 2
Sant'Elena 2
Sant'Ilario d'Enza 2
Santeramo in Colle 2
Santiago de Compostela 2
Sharon 2
Sofia 2
Totale 782
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 635
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 31
Androgen annihilation versus advanced androgen blockage as first line treatment for metastatic castration resistant prostate cancer: A systematic review and meta-analysis 30
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 29
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis 28
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomy 27
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 26
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 25
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 25
How to Select the Optimal Candidates for Renal Mass Biopsy 25
Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: A systematic review and meta-analysis 23
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 23
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 23
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 23
Cabozantinib Plus Durvalumab in Patients With Advanced Urothelial Carcinoma After Platinum Chemotherapy: Safety and Preliminary Activity of the Open-Label, Single-Arm, Phase 2 ARCADIA Trial 23
A Plea for Economically Sustainable Evidence-based Guidelines 23
Estimated Costs Associated With Radiation Therapy for Positive Surgical Margins During Radical Prostatectomy 22
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 21
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 20
Immunotherapy in advanced kidney cancer: an alternative meta-analytic method using reconstructed survival data in case of proportional hazard assumption violation 19
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 19
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 19
Citrullination licenses calpain to decondense nuclei in neutrophil extracellular trap formation 18
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 18
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 17
Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration 17
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 16
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 16
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 15
Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma 15
The obesity paradox in metastatic castration-resistant prostate cancer 14
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 13
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 13
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 13
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 12
RE: Validating the Martini Staging System for Rectourethral Fistula: A Meta-analysis of Postoperative Outcomes 9
UltraPulse Carbon Dioxide Laser Plus Methyl Aminolevulinate-Photodynamic Therapy for the Treatment of Penile Cancer 9
Unexpected Outcomes of Renal Function after Radical Nephrectomy: Histology Relevance along with Clinical Aspects 8
Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients 5
Re: Evaluation of Cause of Death after Radical Cystectomy for Patients with Bladder Cancer: The Impact of Age at the Time of Surgery 3
null 1
Totale 1.397
Categoria #
all - tutte 8.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 1 0 0 0 1 0 0 0
2020/202110 0 0 0 0 0 8 2 0 0 0 0 0
2021/2022109 0 9 1 18 7 6 14 11 5 9 17 12
2022/2023385 74 60 28 21 21 58 27 41 20 5 18 12
2023/2024751 18 21 31 50 53 133 41 156 12 60 71 105
2024/2025140 140 0 0 0 0 0 0 0 0 0 0 0
Totale 1.397